PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole Tablets
Status:
Not yet recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
The study evaluates the pharmacokinetics (PK), safety and tolerability of oxfendazole, after
administration as a tablet formulation in healthy male and female participants.
Phase:
Phase 1
Details
Lead Sponsor:
Swiss Tropical & Public Health Institute
Collaborators:
Drugs for Neglected Diseases Ifakara Health Institute